Nestorone /testosterone

Phase 2Small molecule

KKimberly Myer

Nestorone /testosterone is one of 35 small molecule programs targeting Contraception. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ContraceptionActive, not recruiting

ContraceptionPhase 2

Active, not recruiting

Competition

Competitive Landscape

102 competitors in Contraception

#DrugCompanyPhaseTrials

Carbocaine

Pfizer

Phase 3

1 2

Depo-Provera

Eli Lilly

Phase 3

—3

Feldene

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

2 4

Estradiol Valerate

Yasmin

1 6

Mirena

Bayer

Phase 3

4 7

Opill

LLaboratoire français de Fractionnement et de Biotechnologies

Phase 3

1 8

Norethindrone Acetate

WWatson Pharmaceuticals

Phase 3

2 9

Marvelon

Bayer

Phase 3

1 10

Levonorgestrel and Ethinyl Estradiol

Pfizer

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Testosterone2 trials

Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men

Completed·KKimberly Myer·Phase 1·NCT02432261·44 enrolled

Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males

Completed·KKimberly Myer·Phase 1·NCT02994602·26 enrolled

Contraception1 trial

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Completed·PPremier Research·Phase 2·NCT03452111·420 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Nestorone /testosterone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Nestorone /testosterone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Nestorone /testosterone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Kimberly Myer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: KKimberly Myer

Nestorone /testosterone

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Testosterone2 trials

Contraception1 trial

References

Drug Info

Quick Facts

Related News